Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1285-1291

  Barone, Carla ^a   Grillo, R ^a   Dongiovanni, D ^a   Birocco, N ^a   Rampino, M ^b   Ruo Redda, M G ^b   Garibaldi, E ^b   Munoz, F ^b   Pecorari, G ^b   Cavalot, A ^b   Garzinodemo, P ^b   Buffoni, L ^a   Ciuffreda, L ^a   Ricardi, U ^b   Cortesina, G ^b   Giordano, C ^b   Fasolis, M ^b   Berrone, S ^b   Bertetto, O ^a   Schena, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Chemotherapy; Cisplatin; Head and neck carcinoma; Paclitaxel; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; PACLITAXEL; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG SUBSTITUTION; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; KIDNEY DISEASE; LUNG EMBOLISM; LUNG FIBROSIS; LUNG TUBERCULOSIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 42549109517     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Forastiere A, Koch W, Trotti A and Sidransky D: Head and neck cancer. N Engl J Med 345: 1890-1900, 2001.
2. Stupp R, Weichselbaum RR and Vokes EE: Combined modality therapy of head and neck cancer. Semin Oncol 21(3): 349-358, 1994.
3. Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, Sanguineti G, Bacigalupo A, Badellino F and Margarino G: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Eng J Med 327(16): 1115-1121, 1992.
4. Ang KK, Harris J, Garden AS, Trotti A, Jones CU, Carrascosa L, Cheng JD, Spences SS, Forastiere A and Weber RS: Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol 23(13): 3008-3015, 2005.
5. Pignon JP, Bourhis J, Domenge C and Designè L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individal data. MACH-NC Collaborative Group. Meta-Analyses of Chemotherapy on Head and Neck Cancer. Lancet 355(9208): 949-955, 2000.
6. Pignon JP, Baujat B and Bourhis J: Individual patient data meta-analyses in head and neck carcinoma: what have we learnt? Cancer/Radioterapie 9: 31-36, 2005.
7. Bourhis J: Conventional vs. modified fractionated radiotherapy. Meta-analysis of radiotherapy in head and neck carcinoma: a meta-analysis based on individual patient data. Int J Rad Oncol Biol Phys 54(Suppl): 71-72, 2002.
8. Bourhis J: Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): final analysis. Int J Rad Oncol Biol Phys 60(Suppl): S190-191, 2004.
9. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J and Cooper J: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Eng J Med 349: 2091-2098, 2003.
10. Paccagnella A, Orlando A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, Jirillo A,Tomio L, Fila G and Fede A: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86: 265-272, 1994.
11. Zorat PL, Paccagnella A, Cavaniglia G, Loreggian L, Gava A, Mione CA, Boldrin F, Marchiori C, Lunghi F, Fede A, Bordin A, Da Mosto MC, Sileni VC, Orlando A, Birillo A, Tomio L, Pappagallo GL and Ghi MG: Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-years follow-up. J Natl Cancer Inst 96: 1714-1717, 2004.
12. Forastiere AA: Is there a role for induction chemotherapy in the treatment of head and neck cancer? J Natl Cancer Inst 96(22): 1647-1649, 2004.
13. Adelstein DJ and LeBlanc M: Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? J Clin Oncol 24: 2624-2628, 2006.
14. Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross, DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA and Cooper DL: Cisplatin, fluorouracil and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow up. J Clin Oncol 22: 3061-3069, 2004.
15. Giralt JL, Gonzalez J, del Campo JM, Maldonado J, Sanz X, Pamias J, Eraso A, Bescos S and Raspall G: Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 89(5): 939-945, 2000.
16. Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK and Glisson BS: Phase I/II study of docetaxel, cisplatin and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol 24(25): 4163-4169, 2006.
17. Hitt R, Paz-Ares L, Brandariz A, Castellano D, Pena C, Millan JM, Calvo F, Ortiz de Urbina D, Lopez E, Alvarez-Vicent JJ and Cortés-Funes H: Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long term results of a phase II trials. Arm Oncol 13: 1665-1673, 2002.
18. Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martì JL, Lobo F, Pastor P, Valenti V, Belòn J, Sanchez MA, Chaib C, Pallarés C, Anton A, Cervantes A, Paz-Ares L and Cortés-Funes H: Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23: 8636-8645, 2005.
19. Calais G, Pointreau Y and Alfonsi M: Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Proc ASCO J Clin Oncol Suppl 24: 5506 (abstr 18s), 2006.
20. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Chies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK and Ang KK: Radiotherapy plus cetuximab for squamous cell carcinoma of head and neck. N Eng J Med 354: 567-578, 2006.
21. Miller AB, Hoogstroten B, Staquet M and Winkler A: Reporting results of cancer treatment. Cancer 47(1): 207-214, 1981.
22. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubistein L, Verweij J, VanGlabbeke M, VanOosterom AT, Cristian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92(3): 205-215, 2000.
23. Vermund H, Boysen M, Brandenburg JH, Evensen J, Jacobsen AB, Kaalhus O, Tausjo J, Thorud E, Wiley AL and Winther F: Primary irradiation, surgery or combined therapy in squamous cell carcinoma of the larynx: a comparison of treatment results from two centers. Acta Oncol 29: 489-503, 1990.
24. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, dayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvrie JL, Leupold N, List MA, O'Malley BO, Patel S, Posner MR, Schwartz MA and Wolf GT: American Society of Clinical Oncology practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22): 1-10, 2006.
25. Cmelak AJ, Murphy BA and Burkey BA: Induction chemotherapy (IC) followed by concurrent chemoradiation (CCR) for organ preservation (OP) in locally advanced squamous head and neck cancer (SHNC): results of a phase II trial. Proc ASCO J Clin Oncol Suppl 22: 501 (abstr 2016), 2003.